Judging by the stream of studies in the last few months, it seems the field of gene therapy is beginning to replace its troubled history with the beginnings of a promising future.
In September, linkurl:researchers reported;http://www.nature.com/news/2009/090916/full/news.2009.921.html that viral delivery of a pigment gene allowed colorblind squirrel monkeys to see red and green for the first time, providing hopes that the technique could be used to treat colorblindness in humans. In October, linkurl:transplant scientists showed;http://www.sciencemag.org/cgi/content/abstract/326/5954/818?sa_campaign=Email/toc/6-November-2009/10.1126/science.1171242 they could bolster the health of donor lungs by supplying a gene coding for an anti-inflammatory molecule. Earlier this month came a report in which gene therapy was used to halt the progression of adrenoleukodystrophy, a fatal brain disease, in two young boys using a virus derived from HIV to deliver the gene for the missing enzyme. Finally, linkurl:a study published today (November 11) in Science Translational Medicine;http://stm.sciencemag.org/content/1/6/6ra15.abstract reports that administering...
Image: Stanford University
The ScientistThe ScientistMark KayTSMKTSMKTSMKTSMKTSMKEditor's note (November 12): This post originally referred to the American Society of Gene Therapy. That organization changed its name to the American Society of Gene and Cell Therapy in May, 2009.The post has been updated with the current name.
Interested in reading more?
Become a Member of
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?